ArticleThe Journal of antimicrobial chemotherapy2014

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection.

Dilip Nathwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.